Naloxone, primarily used as an antidote in opioid overdose rather than an alternative maintenance therapy, is currently only available to appropriate practitioners and paramedics. The Executive will follow the recommendations from the current consultation by the Medicine and Healthcare Products Regulatory Agency (MHRA) on extending the use of Naloxone to in...